Drawing for AKT

USPTO serial 99290381

AKT

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
MASON, JARED MICHAEL
Law office
TMO LAW OFFICE 119

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AKT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

Michael T. Smith Birch Stewart Kolasch & Birch, LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for skin wounds; Preparations for the treatment of burns; Pharmaceutical preparations for the treatment of cardiovascular disease and cerebrovascular disease; Pharmaceutical preparations for the treatment of neurological diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of rheumatism; Fever blister treatment preparations; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of organ transplant; Preparation for the relief of pain; Pharmaceutical preparations for the treatment of digestive diseases; Pharmaceutical preparations for the treatment of kidney diseases; Diuretic preparations; immunosuppressive preparations; drug delivery agents; Antidepressants; Pharmaceutical preparations for use in urology; pharmaceutical preparations for use in rheumatology; pharmaceutical preparations for use in nephrology; Pharmaceutical preparations used in organ transplantation; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in orthopedics; pharmaceutical preparations for use in pulmonology; Diagnostic agents, preparations and substances for medical purposes; Nutritional supplements; medical preparations for dental purposes; Medicated toothpaste; Antifungal creams for medical use; Antifungal preparations; Chinese traditional medicinal herbs; Dietetic preparations adapted for medical purposes; Medical dressings; Wound dressings; Capsules sold empty for pharmaceuticals; dental materials; Dietary supplements; Pharmaceutical preparations for the treatment of hematologic disordersACTIVE—
010Heart rate monitors; Blood oxygen monitors; Blood pressure monitors; Respiration monitors; Surgical needles; Surgical pliers; Medical and surgical catheters; Stretchers for patient transport; Artificial limbs; Artificial teeth; medical apparatus and instruments; Body rehabilitation apparatus for medical purposes; orthopedic appliances; Surgical gowns; Surgical capsACTIVE—
041arranging, conducting and organization of seminars in the field of medicine, pharmaceuticals, health, healthcare; arranging, conducting and organization of seminars, workshops, lectures and congresses, all in the field of medicine, pharmaceuticals, health, healthcareACTIVE—
042design and development of medical diagnostic apparatus; design and development of medical technology; computer programming for the medical sector; design and development of computer software for use with medical technology; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; research and development of medicines and pharmaceuticals; provision of information and data relating to medical and pharmaceutical research and development; consultancy relating to medical and pharmaceutical research and development; Scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, pharmacology, biotechnology and bacteriology; provision of information and data relating to scientific and technological research and development; consultancy in the field of scientific research; testing or research on machines, apparatus and instrumentsACTIVE—
044Provision of medical information; providing information in the field of medical and pharmaceutical; Medical and pharmaceutical consultationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 19, 2025MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Dec 19, 2025ABN1ABANDONMENT - EXPRESS MAILED—
Dec 18, 2025EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Dec 8, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2025DOCKASSIGNED TO EXAMINER—
Nov 24, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 18, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 18, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance